Home » Artificial Heart Lung Machines Market
Artificial Heart Lung Machines Market
Published date: Nov 2021 •Formats:
Request Sample Schedule a Call

Global Artificial Heart Lung Machines Market By Type (Single Roller Pump HLM, and Double Roller Pump HLM), By Application (Cardiac Surgery, Lung Transplant Operation, and Acute Respiratory Failure Treatment), By Region and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2019–2028

  • Published date: Nov 2021
  • Report ID: 18330
  • Number of Pages: 365
  • Format:
  • keyboard_arrow_up
    • 1. Artificial Heart Lung Machines Market Introduction
      • 1.1. Definition
      • 1.2. Taxonomy
      • 1.3. Research Scope
    • 2. Executive Summary
      • 2.1. Key Findings by Major Segments
      • 2.2. Top strategies by Major Players
    • 3. Global Artificial Heart Lung Machines Market Overview
      • 3.1. Artificial Heart Lung Machines Market Dynamics
        • 3.1.1. Drivers
        • 3.1.2. Opportunities
        • 3.1.3. Restraints
        • 3.1.4. Challenges
      • 3.2. PESTLE Analysis
      • 3.3. Opportunity Map Analysis
      • 3.4. PORTER'S Five Forces Analysis
      • 3.5. Market Competition Scenario Analysis
      • 3.6. Product Life Cycle Analysis
      • 3.7. Opportunity Orbits
      • 3.8. Manufacturer Intensity Map
    • 4. Global Artificial Heart Lung Machines Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
      • 4.1. Global Artificial Heart Lung Machines Market Analysis by Type: Introduction
      • 4.2. Market Size and Forecast by Region
      • 4.3. Single Roller Pump HLM
      • 4.4. Double Roller Pump HLM
    • 5. Global Artificial Heart Lung Machines Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
      • 5.1. Global Artificial Heart Lung Machines Market Analysis by Application: Introduction
      • 5.2. Market Size and Forecast by Region
      • 5.3. Cardiac Surgery
      • 5.4. Lung Transplant Operation
      • 5.5. Acute Respiratory Failure Treatment
    • 6. Global Artificial Heart Lung Machines Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
      • 6.1. North America
        • 6.1.1. North America Artificial Heart Lung Machines Market: Regional Trend Analysis
          • 6.1.1.1. US
          • 6.1.1.2. Canada
          • 6.1.1.3. Mexico
      • 6.2. Europe
        • 6.2.1. Europe Artificial Heart Lung Machines Market: Regional Trend Analysis
          • 6.2.1.1. Germany
          • 6.2.1.2. France
          • 6.2.1.3. UK
          • 6.2.1.4. Russia
          • 6.2.1.5. Italy
          • 6.2.1.6. Rest of Europe
      • 6.3. Asia-Pacific
        • 6.3.1. Asia-Pacific Artificial Heart Lung Machines Market: Regional Trend Analysis
          • 6.3.1.1. China
          • 6.3.1.2. Japan
          • 6.3.1.3. Korea
          • 6.3.1.4. India
          • 6.3.1.5. Rest of Asia
      • 6.4. Latin America
        • 6.4.1. Latin America Artificial Heart Lung Machines Market: Regional Trend Analysis
          • 6.4.1.1. Brazil
          • 6.4.1.2. Argentina
          • 6.4.1.3. Rest of Latin America
      • 6.5. Middle East and Africa
        • 6.5.1. Middle East and Africa Artificial Heart Lung Machines Market: Regional Trend Analysis
          • 6.5.1.1. GCC
          • 6.5.1.2. South Africa
          • 6.5.1.3. Israel
          • 6.5.1.4. Rest of MEA
    • 7. Global Artificial Heart Lung Machines Market Competitive Landscape, Market Share Analysis, and Company Profiles
      • 7.1. Market Share Analysis
      • 7.2. Company Profiles
      • 7.3. LivaNova (Sorin)
        • 7.3.1. Company Overview
        • 7.3.2. Financial Highlights
        • 7.3.3. Product Portfolio
        • 7.3.4. SWOT Analysis
        • 7.3.5. Key Strategies and Developments
      • 7.4. Getinge (Maquet)
        • 7.4.1. Company Overview
        • 7.4.2. Financial Highlights
        • 7.4.3. Product Portfolio
        • 7.4.4. SWOT Analysis
        • 7.4.5. Key Strategies and Developments
      • 7.5. Medtronic
        • 7.5.1. Company Overview
        • 7.5.2. Financial Highlights
        • 7.5.3. Product Portfolio
        • 7.5.4. SWOT Analysis
        • 7.5.5. Key Strategies and Developments
      • 7.6. Terumo CV Group
        • 7.6.1. Company Overview
        • 7.6.2. Financial Highlights
        • 7.6.3. Product Portfolio
        • 7.6.4. SWOT Analysis
        • 7.6.5. Key Strategies and Developments
      • 7.7. Braile Biomedica
        • 7.7.1. Company Overview
        • 7.7.2. Financial Highlights
        • 7.7.3. Product Portfolio
        • 7.7.4. SWOT Analysis
        • 7.7.5. Key Strategies and Developments
      • 7.8. Tianjin Medical
        • 7.8.1. Company Overview
        • 7.8.2. Financial Highlights
        • 7.8.3. Product Portfolio
        • 7.8.4. SWOT Analysis
        • 7.8.5. Key Strategies and Developments
    • 8. Assumptions and Acronyms
    • 9. Research Methodology
    • 10. Contact
    • LivaNova (Sorin)
    • Getinge (Maquet)
    • Medtronic
    • Terumo CV Group
    • Braile Biomedica
    • Tianjin Medical
  • settingsSettings

Related Reports

Our Clients

  • Our Clients
Inquiry Before Buying

Artificial Heart Lung Machines Market
  • 18330
  • Nov 2021
    • ★★★★★
      ★★★★★
    • (109)
  • US $5,999
    US $2,999
  • US $7,999
    US $3,499
  • US $12,999
    US $4,499
Buy Now
✖
Request a Sample Report
We'll get back to you as quickly as possible

Single User
$5,999
$2,999
USD / per unit
save 50%
 Multi User
$7,999
$3,499
USD / per unit
save 55%
 Corporate User
$12,999
$4,499
USD / per unit
save 65%
e-Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization No up to 10 hrs work up to 30 hrs work
Accessibility 1 User 2-5 User Unlimited
Analyst Support up to 20 hrs up to 40 hrs up to 50 hrs
Benefit Up to 20% off on next purchase Up to 25% off on next purchase Up to 30% off on next purchase
Buy Now ($ 2,999)Buy Now ($ 3,499)Buy Now ($ 4,499)
Find Help
Legal
Explore